FHB
CRL icon

First Hawaiian Bank’s Charles River Laboratories CRL Stock Holding History

First Hawaiian Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,476
Closed -$826K – 240
2024
Q4 		$826K Sell
4,476
-6,071
-58% -$1.17M 0.03% 477
2024
Q3 		$2.08M Sell
10,547
-1,748
-14% -$363K 0.07% 228
2024
Q2 		$2.54M Sell
12,295
-1,509
-11% -$342K 0.09% 166
2024
Q1 		$3.74M Sell
13,804
-10
-0.1% -$2.39K 0.12% 121
2023
Q4 		$3.27M Sell
13,814
-127
-0.9% -$25K 0.1% 137
2023
Q3 		$2.73M Sell
13,941
-15
-0.1% -$3.08K 0.09% 159
2023
Q2 		$2.93M Buy
13,956
+1,219
+10% +$243K 0.1% 154
2023
Q1 		$2.57M Sell
12,737
-9
-0.1% -$2.04K 0.09% 170
2022
Q4 		$2.78M Buy
12,746
+888
+7% +$194K 0.1% 150
2022
Q3 		$2.33M Sell
11,858
-6
-0.1% -$1.29K 0.09% 164
2022
Q2 		$2.54M Sell
11,864
-3,190
-21% -$779K 0.09% 161
2022
Q1 		$4.28M Sell
15,054
-137
-0.9% -$42.2K 0.13% 102
2021
Q4 		$5.72M Buy
15,191
+8,406
+124% +$3.27M 0.17% 76
2021
Q3 		$2.8M Sell
6,785
-2,250
-25% -$934K 0.11% 112
2021
Q2 		$3.34M Buy
9,035
+2,699
+43% +$901K 0.14% 89
2021
Q1 		$1.84M Sell
6,336
-31
-0.5% -$8.62K 0.08% 177
2020
Q4 		$1.59M Sell
6,367
-1,142
-15% -$272K 0.07% 195
2020
Q3 		$1.7M Sell
7,509
-1,578
-17% -$327K 0.09% 165
2020
Q2 		$1.58M Sell
9,087
-1,357
-13% -$217K 0.08% 175
2020
Q1 		$1.32M Buy
10,444
+5,985
+134% +$898K 0.08% 176
2019
Q4 		$682K Sell
4,459
-966
-18% -$134K 0.03% 363
2019
Q3 		$718K Buy
5,425
+78
+1% +$10.5K 0.04% 344
2019
Q2 		$759K Buy
5,347
+14
+0.3% +$1.9K 0.04% 312
2019
Q1 		$775K Sell
5,333
-389
-7% -$51.1K 0.04% 310
2018
Q4 		$647K Sell
5,722
-61
-1% -$7.64K 0.04% 328
2018
Q3 		$778K Buy
+5,783
New +$714K 0.04% 337

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Hawaiian Bank's CRL Position: Q1 2025 in Review

First Hawaiian Bank sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 4,476 shares — an estimated $826K sold.

First Hawaiian Bank first reported a position in CRL in Q3 2018 and held it in 26 quarters. The position peaked at $5.72M in Q4 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • First Hawaiian Bank reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 4,476 Charles River Laboratories shares in Q1 2025, an estimated $826K.
  • First Hawaiian Bank first reported a position in Charles River Laboratories in Q3 2018 and held it in 26 quarters.
  • First Hawaiian Bank's Charles River Laboratories position peaked at $5.72M in Q4 2021.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.